Sage Journals: Discover world-class research

Retricted access

Research article

First published 2022-8

The risk of infections for multiple sclerosis and neuromyelitis optica spectrum disorder disease-modifying treatments: Eighth European Committee for Treatment and Research in Multiple Sclerosis Focused Workshop Review. April 2021

Carmen Tur, Anne-Laure Dubessy, Susana Otero-Romero [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2023-12

Interplay between age and disease-modifying treatments in influencing infection risk in multiple sclerosis

Sarah Lena Susanna Jacober, Giulio Disanto, Rosaria Sacco [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2021-8

Age-related adverse events of disease-modifying treatments for multiple sclerosis: A meta-regression

Luca Prosperini, Shalom Haggiag, Carla Tortorella [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2022-6

Increased rate of hospitalisation for COVID-19 among rituximab-treated multiple sclerosis patients: A study of the Swedish multiple sclerosis registry

Tim Spelman, Lars Forsberg, Kyla McKay [...]

Multiple Sclerosis Journal

Retricted access

Review article

First published 2023-08

Effect of Disease-Modifying Therapies on COVID-19 Vaccination Efficacy in Multiple Sclerosis Patients: A Comprehensive Review

Elham Jamali, Shima Shapoori, Majid Reza Farrokhi [...]

Viral Immunology

Open access

Research article

First published 2021-12

Humoral immune response after COVID-19 in multiple sclerosis: A nation-wide Austrian study

Gabriel Bsteh, Sophie Dürauer, Hamid Assar [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2025-10

Human papillomavirus–related conditions in women with multiple sclerosis receiving disease-modifying therapies: A Pharmacovigilance disproportionality analysis from the WHO vigibase®

Constance Bordet, Oumaïma Maachi, Anne-Caroline Papeix [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2023-7

Vaccine-breakthrough SARS-CoV-2 infections in people with multiple sclerosis and related conditions: An observational study by the New York COVID-19 Neuro-Immunology Consortium (NYCNIC-2)

Sylvia Klineova, Rebecca Straus Farber, Tracy DeAngelis [...]

Multiple Sclerosis Journal

Retricted access

Review article

First published 2018-7

Aging and lymphocyte changes by immunomodulatory therapies impact PML risk in multiple sclerosis patients

Elizabeth A Mills, Yang Mao-Draayer

Multiple Sclerosis Journal

Open access

Review article

First published 2023-5

T cell responses to COVID-19 infection and vaccination in patients with multiple sclerosis receiving disease-modifying therapy

Anthony T Reder, Olaf Stuve, Stephanie K Tankou [...]

Multiple Sclerosis Journal

Search results